CTS Spotlight at 2018 AABB Annual Meeting
Sunday, October 14, 2018 at 1:30 PM: Scientific Oral Abstract Plenary Session (BBC57) Multicenter Clinical Evaluation of a Babesia Transcription-Mediated Amplification Assay on a Fully Automated System Phillip C. Williamson, Ph.D.
Monday, October 15, 2018 at 2:30PM: (BBC2-MN3-24) Recently Acquired Hepatitis C Infections in US Blood Donors: Genotype and Geographic Distribution of NAT Yield Blood Donations across the Continental US Valerie Winkelman and Phillip C. Williamson, Ph.D.
Tuesday, October 16, 2018 at 11:45AM a: (PHP2 - TU3-23) Characteristics of HIV Infections, Including Genotypes and Drug Resistance Mutations, in Blood Donors in the US Phillip C. Williamson, Ph.D.
We received an updated WNV package insert; please note the manufacturer and license number has been ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...